🟢 Xenetic Biosciences is trading 6.61% up in pre-market on October 5, 2026 with no clear catalyst

Xenetic Biosciences is trading at $2.39, up +6.61%, with no clear catalyst identified.

• Shares are up from the October 2 close of $2.24.
• No October 5 company announcement was identified. The latest release listed on the company’s press-release page is its September 16 share-exchange announcement with Santersus, which does not establish a reason for the pre-market gain.
• Major U.S. indices were slightly lower in the supplied pre-market context; available evidence does not establish a specific reason for the move.